Epigenetic de-repression of drivers of neuroendocrine prostate cancer [RNA-seq]
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer ProgressionCancer research · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE287183_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1211564 and SRA study SRP557950. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8740612 WCM154_sgINC_rep1 WCM154_sgINC
- GSM8740613 WCM154_sgINC_rep2 WCM154_sgINC
- GSM8740614 WCM154_sgINC_rep3 WCM154_sgINC
- GSM8740615 WCM154_sgPROX1_1_rep1 WCM154_sgPROX1_1
- GSM8740616 WCM154_sgPROX1_1_rep2 WCM154_sgPROX1_1
- GSM8740617 WCM154_sgPROX1_1_rep3 WCM154_sgPROX1_1
- GSM8740618 C42_ctrl_rep1 C42_ctrl
- GSM8740619 C42_ctrl_rep2 C42_ctrl
- GSM8740620 C42_ctrl_rep3 C42_ctrl
- GSM8740621 C42_PROX1_OE_rep1 C42_PROX1_OE
- GSM8740622 C42_PROX1_OE_rep2 C42_PROX1_OE
- GSM8740623 C42_PROX1_OE_rep3 C42_PROX1_OE
- GSM8740624 22Rv1_ctrl_rep1 22Rv1_ctrl
- GSM8740625 22Rv1_ctrl_rep2 22Rv1_ctrl
- GSM8740626 22Rv1_ctrl_rep3 22Rv1_ctrl
- GSM8740627 22Rv1_PROX1_OE_rep1 22Rv1_PROX1_OE
- GSM8740628 22Rv1_PROX1_OE_rep2 22Rv1_PROX1_OE
- GSM8740629 22Rv1_PROX1_OE_rep3 22Rv1_PROX1_OE
- GSM8740630 WCM154_sgPROX1_2_rep1 WCM154_sgPROX1_2
- GSM8740631 WCM154_sgPROX1_2_rep2 WCM154_sgPROX1_2
- GSM8740632 WCM154_sgPROX1_2_rep3 WCM154_sgPROX1_2
- GSM8740633 WCM154_rescue_dT_PROX1_veh_rep1 WCM154_rescue_dT_PROX1_…
- GSM8740634 WCM154_rescue_dT_PROX1_veh_rep2 WCM154_rescue_dT_PROX1_…
- GSM8740635 WCM154_rescue_dT_PROX1_veh_rep3 WCM154_rescue_dT_PROX1_…
- GSM8740636 WCM154_rescue_dT_PROX1_dTAG_8hr_rep1 WCM154_rescue_dT_PROX1_…
- GSM8740637 WCM154_rescue_dT_PROX1_dTAG_8hr_rep2 WCM154_rescue_dT_PROX1_…
- GSM8740638 WCM154_rescue_dT_PROX1_dTAG_8hr_rep3 WCM154_rescue_dT_PROX1_…
- GSM8740639 WCM154_rescue_dT_PROX1_dTAG_48hr_rep1 WCM154_rescue_dT_PROX1_…
- GSM8740640 WCM154_rescue_dT_PROX1_dTAG_48hr_rep2 WCM154_rescue_dT_PROX1_…
- GSM8740641 WCM154_rescue_dT_PROX1_dTAG_48hr_rep3 WCM154_rescue_dT_PROX1_…
- GSM8740642 WCM1078_taz_rep1 WCM1078_taz
- GSM8740643 WCM1078_taz_rep2 WCM1078_taz
- GSM8740644 WCM1078_taz_rep3 WCM1078_taz
- GSM8740645 WCM1078_veh_rep1 WCM1078_veh
- GSM8740646 WCM1078_veh_rep2 WCM1078_veh
- GSM8740647 WCM1078_veh_rep3 WCM1078_veh
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE234181 Long-term multi-modal recording reveals epigenetic adaptation routes in dormant breast cancer cells [scRNA-Seq] 184 samples shares epigenetic, rna-seq
- GSE295392 PIKfyve-regulated lipid metabolism as a therapeutic vulnerability in neuroendocrine prostate cancer 82 samples shares neuroendocrine, prostate
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.